MyAverix Finance
HK · Healthcare
Hansoh Pharmaceutical Group Co Ltd (3692)
Drug Manufacturers - Specialty & Generic
Hansoh Pharmaceutical Group Co Ltd (3692) is listed on HK in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-21, reported market cap is $205.66B, P/E ratio is 31.70, net margin is 37.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3692
Hansoh Pharmaceutical Group Co Ltd (3692) — FAQ
What is Hansoh Pharmaceutical Group Co Ltd's market cap?
Hansoh Pharmaceutical Group Co Ltd (3692) has a reported market cap of $205.66B (data as of 2026-05-21).
What is 3692's P/E ratio?
The price-to-earnings (P/E) ratio for Hansoh Pharmaceutical Group Co Ltd (3692) is 31.70 (data as of 2026-05-21).
Does Hansoh Pharmaceutical Group Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Hansoh Pharmaceutical Group Co Ltd (3692). Check the MyAverix Finance app for the latest dividend data.
What sector is Hansoh Pharmaceutical Group Co Ltd in?
Hansoh Pharmaceutical Group Co Ltd (3692) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 3692 listed on?
3692 is listed on HK.
What is Hansoh Pharmaceutical Group Co Ltd's net margin?
Hansoh Pharmaceutical Group Co Ltd (3692) reports a net margin of 37.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.